iHear MatriX vs Signia Pure C&G IX

The iHear MatriX is a behind-the-ear OTC hearing aid priced at $499, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This places it in the top 40% of OTC hearing aids, offering solid performance at a budget-friendly price point. In our testing, the MatriX demonstrated notable strengths in speech intelligibility. Speech in quiet scored a solid 4.0/5, measuring 1.17 points above the category average. Speech in noise performance came in at 2.4/5—above the category average by 0.96 points, though only mixed in absolute terms. Feedback handling was excellent at 5.0/5, surpassing the already-strong category average by 0.46 points, meaning users can expect reliable stability without whistling during typical wear. The most significant limitation is music streaming, which scored 0.0/5—a full 1.92 points below the category average. Users who prioritize streaming audio from their phone should consider alternatives. Own-voice comfort measured 2.7/5, slightly above category average but still mixed in absolute terms. The MatriX features rechargeable batteries and supports streaming from both iPhone and Android devices. With a normalized Initial Score of 3.7/5 improving to 4.3/5 after tuning, this hearing aid responds well to optimization. It's best suited for users who prioritize speech clarity and feedback-free wear over music streaming quality, and who want a budget OTC option that delivers above-average speech performance in our lab framework.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.